{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:26:04Z","timestamp":1792599964456,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s43032-020-00368-3","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T14:02:45Z","timestamp":1604066565000},"page":"745-756","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["NFAT Overexpression Correlates with CA72-4 and Poor Prognosis of Ovarian Clear-Cell Carcinoma Subtype"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5612-4481","authenticated-orcid":false,"given":"Bing","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Qiang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Si","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"issue":"4","key":"368_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284\u201396. https:\/\/doi.org\/10.3322\/caac.21456.","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 5","key":"368_CR2","doi-asserted-by":"publisher","first-page":"v23","DOI":"10.1093\/annonc\/mdq244","volume":"21","author":"N Colombo","year":"2010","unstructured":"Colombo N, Peiretti M, Parma G, Lapresa M, Mancari R, Carinelli S, et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):v23\u201330. https:\/\/doi.org\/10.1093\/annonc\/mdq244.","journal-title":"Ann Oncol"},{"issue":"10","key":"368_CR3","first-page":"649","volume":"43","author":"Z Lu","year":"2014","unstructured":"Lu Z, Chen J. Introduction of WHO classification of tumours of female reproductive organs, fourth edition. Zhonghua Bing Li Xue Za Zhi. 2014;43(10):649\u201350.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"1","key":"368_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.5732\/cjc.014.10273","volume":"34","author":"M Devouassoux-Shisheboran","year":"2015","unstructured":"Devouassoux-Shisheboran M, Genestie C. Pathobiology of ovarian carcinomas. Chin J Cancer. 2015;34(1):50\u20135. https:\/\/doi.org\/10.5732\/cjc.014.10273.","journal-title":"Chin J Cancer"},{"issue":"4","key":"368_CR5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","volume":"186","author":"RJ Kurman","year":"2016","unstructured":"Kurman RJ, Shih IM. The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded. Am J Pathol. 2016;186(4):733\u201347. https:\/\/doi.org\/10.1016\/j.ajpath.2015.11.011.","journal-title":"Am J Pathol"},{"issue":"3","key":"368_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/uog.17557","volume":"51","author":"KB Mathieu","year":"2018","unstructured":"Mathieu KB, Bedi DG, Thrower SL, Qayyum A, Bast RC Jr. Screening for ovarian cancer: imaging challenges and opportunities for improvement. Ultrasound Obstet Gynecol. 2018;51(3):293\u2013303. https:\/\/doi.org\/10.1002\/uog.17557.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"368_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa020177","volume":"348","author":"L Zhang","year":"2003","unstructured":"Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med. 2003;348(3):203\u201313. https:\/\/doi.org\/10.1056\/NEJMoa020177.","journal-title":"N Engl J Med"},{"issue":"4","key":"368_CR8","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1128\/mcb.8.4.1715","volume":"8","author":"DB Durand","year":"1988","unstructured":"Durand DB, Shaw JP, Bush MR, Replogle RE, Belagaje R, Crabtree GR. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol Cell Biol. 1988;8(4):1715\u201324. https:\/\/doi.org\/10.1128\/mcb.8.4.1715.","journal-title":"Mol Cell Biol"},{"key":"368_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1126\/science.3260404","volume":"241","author":"JP Shaw","year":"1988","unstructured":"Shaw JP, Utz PJ, Durand DB, Toole JJ, Emmel EA, Crabtree GR. Identification of a putative regulator of early T cell activation genes. Science. 1988;241:202\u20135 Journal of immunology (Baltimore, Md : 1950). 2010;185(9):4972\u20135.","journal-title":"Science"},{"issue":"2","key":"368_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.immuni.2015.01.006","volume":"42","author":"GJ Martinez","year":"2015","unstructured":"Martinez GJ, Pereira RM, Aijo T, Kim EY, Marangoni F, Pipkin ME, et al. The transcription factor NFAT promotes exhaustion of activated CD8(+) T cells. Immunity. 2015;42(2):265\u201378. https:\/\/doi.org\/10.1016\/j.immuni.2015.01.006.","journal-title":"Immunity."},{"issue":"20","key":"368_CR11","doi-asserted-by":"publisher","first-page":"9959","DOI":"10.1073\/pnas.1820604116","volume":"116","author":"GP Mognol","year":"2019","unstructured":"Mognol GP, Gonzalez-Avalos E, Ghosh S, Spreafico R, Gudlur A, Rao A, et al. Targeting the NFAT:AP-1 transcriptional complex on DNA with a small-molecule inhibitor. Proc Natl Acad Sci U S A. 2019;116(20):9959\u201368. https:\/\/doi.org\/10.1073\/pnas.1820604116.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"368_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1182\/blood.2019001866","volume":"135","author":"P Bucher","year":"2020","unstructured":"Bucher P, Erdmann T, Grondona P, Xu W, Schmitt A, Schurch C, et al. Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphoma. Blood. 2020;135(2):121\u201332. https:\/\/doi.org\/10.1182\/blood.2019001866.","journal-title":"Blood."},{"issue":"17","key":"368_CR13","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1080\/15384101.2016.1203485","volume":"15","author":"LK Teixeira","year":"2016","unstructured":"Teixeira LK, Carrossini N, Secca C, Kroll JE, DaCunha DC, Faget DV, et al. NFAT1 transcription factor regulates cell cycle progression and cyclin E expression in B lymphocytes. Cell Cycle. 2016;15(17):2346\u201359. https:\/\/doi.org\/10.1080\/15384101.2016.1203485.","journal-title":"Cell Cycle"},{"issue":"1","key":"368_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1478-811X-10-16","volume":"10","author":"E Serfling","year":"2012","unstructured":"Serfling E, Avots A, Klein-Hessling S, Rudolf R, Vaeth M, Berberich-Siebelt F. NFATc1\/alphaA: the other face of NFAT factors in lymphocytes. Cell Commun Signal. 2012;10(1):16. https:\/\/doi.org\/10.1186\/1478-811X-10-16.","journal-title":"Cell Commun Signal"},{"issue":"12","key":"368_CR15","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1182\/blood-2005-03-1167","volume":"106","author":"LV Pham","year":"2005","unstructured":"Pham LV, Tamayo AT, Yoshimura LC, Lin-Lee YC, Ford RJ. Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival. Blood. 2005;106(12):3940\u20137. https:\/\/doi.org\/10.1182\/blood-2005-03-1167.","journal-title":"Blood."},{"issue":"6","key":"368_CR16","doi-asserted-by":"publisher","first-page":"e66008","DOI":"10.1371\/journal.pone.0066008","volume":"8","author":"X Tie","year":"2013","unstructured":"Tie X, Han S, Meng L, Wang Y, Wu A. NFAT1 is highly expressed in, and regulates the invasion of, glioblastoma multiforme cells. PLoS One. 2013;8(6):e66008. https:\/\/doi.org\/10.1371\/journal.pone.0066008.","journal-title":"PLoS One"},{"issue":"3","key":"368_CR17","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1053\/j.gastro.2009.10.045","volume":"138","author":"A Koenig","year":"2010","unstructured":"Koenig A, Linhart T, Schlengemann K, Reutlinger K, Wegele J, Adler G, et al. NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells. Gastroenterology. 2010;138(3):1189\u201399.e1\u20132. https:\/\/doi.org\/10.1053\/j.gastro.2009.10.045.","journal-title":"Gastroenterology"},{"issue":"17","key":"368_CR18","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1158\/0008-5472.CAN-11-4155","volume":"72","author":"K Gerlach","year":"2012","unstructured":"Gerlach K, Daniel C, Lehr HA, Nikolaev A, Gerlach T, Atreya R, et al. Transcription factor NFATc2 controls the emergence of colon cancer associated with IL-6-dependent colitis. Cancer Res. 2012;72(17):4340\u201350. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-4155.","journal-title":"Cancer Res"},{"issue":"27","key":"368_CR19","doi-asserted-by":"publisher","first-page":"23342","DOI":"10.18632\/oncotarget.4344","volume":"6","author":"TH Wang","year":"2015","unstructured":"Wang TH, Lin YS, Chen Y, Yeh CT, Huang YL, Hsieh TH, et al. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition. Oncotarget. 2015;6(27):23342\u201357. https:\/\/doi.org\/10.18632\/oncotarget.4344.","journal-title":"Oncotarget"},{"key":"368_CR20","doi-asserted-by":"publisher","first-page":"29256","DOI":"10.1038\/srep29256","volume":"6","author":"CC Huang","year":"2016","unstructured":"Huang CC, Lee CC, Lin HH, Chang JY. Cathepsin S attenuates endosomal EGFR signalling: a mechanical rationale for the combination of cathepsin S and EGFR tyrosine kinase inhibitors. Sci Rep. 2016;6:29256. https:\/\/doi.org\/10.1038\/srep29256.","journal-title":"Sci Rep"},{"issue":"34","key":"368_CR21","doi-asserted-by":"publisher","first-page":"20914","DOI":"10.1074\/jbc.271.34.20914","volume":"271","author":"J Park","year":"1996","unstructured":"Park J, Takeuchi A, Sharma S. Characterization of a new isoform of the NFAT (nuclear factor of activated T cells) gene family member NFATc. J Biol Chem. 1996;271(34):20914\u201321. https:\/\/doi.org\/10.1074\/jbc.271.34.20914.","journal-title":"J Biol Chem"},{"issue":"7","key":"368_CR22","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/ncb816","volume":"4","author":"S Jauliac","year":"2002","unstructured":"Jauliac S, Lopez-Rodriguez C, Shaw LM, Brown LF, Rao A, Toker A. The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol. 2002;4(7):540\u20134. https:\/\/doi.org\/10.1038\/ncb816.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"368_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1042\/bj20110530","volume":"440","author":"GK Yiu","year":"2011","unstructured":"Yiu GK, Kaunisto A, Chin YR, Toker A. NFAT promotes carcinoma invasive migration through glypican-6. Biochem J. 2011;440(1):157\u201366. https:\/\/doi.org\/10.1042\/bj20110530.","journal-title":"Biochem J"},{"issue":"19","key":"368_CR24","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1038\/sj.onc.1204386","volume":"20","author":"F Macian","year":"2001","unstructured":"Macian F, Lopez-Rodriguez C, Rao A. Partners in transcription: NFAT and AP-1. Oncogene. 2001;20(19):2476\u201389. https:\/\/doi.org\/10.1038\/sj.onc.1204386.","journal-title":"Oncogene."},{"issue":"15","key":"368_CR25","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1038\/sj.emboj.7601246","volume":"25","author":"M Buchholz","year":"2006","unstructured":"Buchholz M, Schatz A, Wagner M, Michl P, Linhart T, Adler G, et al. Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+\/calcineurin signaling pathway. EMBO J. 2006;25(15):3714\u201324. https:\/\/doi.org\/10.1038\/sj.emboj.7601246.","journal-title":"EMBO J"},{"key":"368_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/978-1-4020-6191-2_15","volume":"45","author":"T Capiod","year":"2007","unstructured":"Capiod T, Shuba Y, Skryma R, Prevarskaya N. Calcium signalling and cancer cell growth. Subcell Biochem. 2007;45:405\u201327. https:\/\/doi.org\/10.1007\/978-1-4020-6191-2_15.","journal-title":"Subcell Biochem"},{"issue":"5","key":"368_CR27","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nm.4072","volume":"22","author":"K Peuker","year":"2016","unstructured":"Peuker K, Muff S, Wang J, Kunzel S, Bosse E, Zeissig Y, et al. Epithelial calcineurin controls microbiota-dependent intestinal tumor development. Nat Med. 2016;22(5):506\u201315. https:\/\/doi.org\/10.1038\/nm.4072.","journal-title":"Nat Med"},{"key":"368_CR28","doi-asserted-by":"publisher","first-page":"e1658","DOI":"10.1038\/cddis.2015.14","volume":"6","author":"CT Quang","year":"2015","unstructured":"Quang CT, Leboucher S, Passaro D, Fuhrmann L, Nourieh M, Vincent-Salomon A, et al. The calcineurin\/NFAT pathway is activated in diagnostic breast cancer cases and is essential to survival and metastasis of mammary cancer cells. Cell Death Dis. 2015;6:e1658. https:\/\/doi.org\/10.1038\/cddis.2015.14.","journal-title":"Cell Death Dis"},{"issue":"1","key":"368_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13048-019-0550-0","volume":"12","author":"B Xin","year":"2019","unstructured":"Xin B, Ji KQ, Liu YS, Zhao XD. Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer. J Ovarian Res. 2019;12(1):75. https:\/\/doi.org\/10.1186\/s13048-019-0550-0.","journal-title":"J Ovarian Res"},{"issue":"4","key":"368_CR30","first-page":"2311","volume":"22","author":"M Carpelan-Holmstrom","year":"2002","unstructured":"Carpelan-Holmstrom M, Louhimo J, Stenman UH, Alfthan H, Haglund C. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res. 2002;22(4):2311\u20136.","journal-title":"Anticancer Res"},{"issue":"1","key":"368_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3343\/alm.2020.40.1.40","volume":"40","author":"KH Shin","year":"2020","unstructured":"Shin KH, Kim HH, Kwon BS, Suh DS, Joo JK, Kim KH. Clinical usefulness of cancer antigen (CA) 125, human epididymis 4, and CA72-4 levels and risk of ovarian malignancy algorithm values for diagnosing ovarian tumors in Korean patients with and without endometriosis. Ann Lab Med. 2020;40(1):40\u20137. https:\/\/doi.org\/10.3343\/alm.2020.40.1.40.","journal-title":"Ann Lab Med"},{"issue":"1","key":"368_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2217\/fon.11.135","volume":"8","author":"BM Nolen","year":"2012","unstructured":"Nolen BM, Lokshin AE. Protein biomarkers of ovarian cancer: the forest and the trees. Future Oncol. 2012;8(1):55\u201371. https:\/\/doi.org\/10.2217\/fon.11.135.","journal-title":"Future Oncol"},{"issue":"5","key":"368_CR33","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s13277-012-0381-8","volume":"33","author":"T Granato","year":"2012","unstructured":"Granato T, Midulla C, Longo F, Colaprisca B, Frati L, Anastasi E. Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer. Tumour Biol. 2012;33(5):1335\u20139. https:\/\/doi.org\/10.1007\/s13277-012-0381-8.","journal-title":"Tumour Biol"},{"issue":"5","key":"368_CR34","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1515\/cclm.2009.134","volume":"47","author":"MS Lenhard","year":"2009","unstructured":"Lenhard MS, Nehring S, Nagel D, Mayr D, Kirschenhofer A, Hertlein L, et al. Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors. Clin Chem Lab Med. 2009;47(5):537\u201342. https:\/\/doi.org\/10.1515\/cclm.2009.134.","journal-title":"Clin Chem Lab Med"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-020-00368-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s43032-020-00368-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-020-00368-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T17:42:10Z","timestamp":1612460530000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s43032-020-00368-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["368"],"URL":"https:\/\/doi.org\/10.1007\/s43032-020-00368-3","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,30]]},"assertion":[{"value":"31 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study was approved by the Ethics Committee of ShengJing Hospital (No. 2017PS233K).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent was obtained from each patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}]}}